RSM logo
International Journal of STD & AIDS

Home Current issue Browse archive Alerts About the journal Feedback
 
Int J STD AIDS 2007;18:543-545
doi:10.1258/095646207781439766
© 2007 Royal Society of Medicine Press

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rizzo-Price, P.
Right arrow Articles by Gaydos, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original research articles

Can nucleic acid amplification tests be used to test for chlamydia and gonorrhoea in microbicide trials?

Patricia Rizzo-Price, Paul D Stamper, Billie Jo Wood, Steven J Reynolds, Thomas C Quinn and Charlotte Gaydos

Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA; Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

Microbicides may interfere with detection of Chlamydia trachomatis (Ct) and Neisseria gonorrhoeae (Ng) in urine samples from women who use microbicides. The inhibitory effects of BufferGel, PRO2000 and PRO2000 placebo, in urine samples, were determined by nucleic acid amplification tests (NAATs). Uninfected urine was inoculated with different concentrations (105–101 organisms/mL); microbicides were added to achieve final concentrations from 5% to 0.1%. Specimens were tested using strand displacement amplification (SDA) for Ct and Ng. Samples with BufferGel demonstrated no inhibition. Samples with PRO2000 showed inhibition at the 5% concentration when tested for Ct, whereas for Ng, PRO2000 showed inhibition at 5%, 2% and some 1% concentrations. The placebo showed no inhibition when detecting Ct, and variable inhibition at the 5% and 2% concentrations for Ng. The potential inhibitory effects of microbicides on the NAATs selected for detection of Ct and Ng should be considered in clinical trials involving topical microbicides.

Key Words: MICROBICIDES • PRO2000 • BUFFERGEL


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
B. J. Wood, P. Rizzo-Price, J. Holden, A. Hardick, T. C. Quinn, and C. A. Gaydos
The Microbicide Tenofovir Does Not Inhibit Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Samples
J. Clin. Microbiol., February 1, 2008; 46(2): 763 - 765.
[Abstract] [Full Text] [PDF]



How Not to be a Doctor